摘要
目的探讨改良森田疗法对强迫症的疗效。方法以ICD-10诊断标准选择病例,随机分组;分为改良森田组(简称改良组)57例,传统森田加药物合并组(简称合并组)55例与传统森田组(简称传统组)53例,进行对照研究。评价工具:YBOCS、HAMA、SDSS、中华医学会神经精神科分会五级疗效评定标准。结果改良组、传统组、合并组出院治疗效果无显著差异;住院初期患者依从性、YBOCS、HANA减分率合并组>改良组>传统组;合并组远期复发率显著高于传统组,提示药物使临床症状较早减轻,产生假愈使临床医生误判;改良组加入认知疗法,可降低患者的焦虑、抑郁情绪,提高依从性,并降低远期复发率。结论改良森田疗法对强迫症的治愈率明显提高,远期复发率显著降低,治疗依从性提高,值得推广应用。
Objective To study the efficacy of Morita Therapy on the treatment of obsessive-compulsive neurosis. Methods The adoption checked against a random method. Patients were screened that match the ICD-10 diagnostic standard to go into a set of random and assigned Classical Morita Therapy group（CMT）, Classical Morita Therapy combined with Clomipramine group （CMTC） and Modified Morita Therapy group（MMT）, The three groups have 57, 55 and 53 patients; adopting an airtight of YBOCS, HAMA, SDSS. Results The effects of treatment of 3 groups are basic equivalent. YBOCS and HANA reducti rate of the patients of CMTC are higher than one of MMT and even more higher than that of CMT. Long recurring rate of CMTC higher than CMT and even more higher than that of MMT. Drug increased the recurring probability, which is shown that drug made the symptom disappear so soon that clinic curing feint appeared. The doctors misjudged and decided to let the patients leave hospital too early. Cognitive therapy of MMT reduced the anxiety and depressiveness and raised the compliance of the patients. Long term recurring rate is remarkably decreased in MMT. Conclusion The curing rate of MMT on the treatment of obsessive-compulsive neurosis is remarkably increased and long recurring rate is remarkably decreased. MMT is worth promoting and applying.
出处
《中国健康心理学杂志》
2008年第9期1055-1057,共3页
China Journal of Health Psychology
基金
2007年河北省科学技术研究与发展指导计划(第一批)项目
课题编号:072761255
关键词
改良森田疗法
强迫症
氯丙咪嗪
Modified morita therapy
Obsessive-compulsive neurosis
Clomipramine
